bit.bio defends European patent for ‘novel’ opti-ox technology
bit.bio’s method for pluripotent stem cell (PSC) programming, opti-ox, was deemed sufficiently novel and inventive.
bit.bio’s method for pluripotent stem cell (PSC) programming, opti-ox, was deemed sufficiently novel and inventive.
What's Your Reaction?
